MyAlcon | Country
MyAlcon Global Sites
Americas
Europe / Middle East / Africa
United Kingdom - English
Asia Pacific
India - English
COMING SOON
Americas
Brazil
Mexico
Colombia
Chile
Argentina
Ecuador
Peru
Uruguay
Europe / Middle East / Africa
Spain
Italy
France
Russia
Asia Pacific
South Korea
China
Hong Kong
Singapore
Clareon®
PanOptix®
Trifocal IOL
Ready to satisfy your patients with a full range of vision and high rate of spectacle independence?1-3
Clareon® PanOptix® Trifocal IOL
Ready to satisfy your patients with a full range of vision and high rate of spectacle independence?1-3
PanOptix® Provides 20/20 Vision at Near, Intermediate and Far1*†
*Based on mean value of binocular defocus curve at near, intermediate and distance at 6 months (n=127).
†Snellen VA was converted from logMAR VA. A Snellen notation of 20/20 or better indicates a logMAR VA of 0.04 or better, which means 3 or more of the 5 ETDRS chart letters in the line were identified correctly.
Offer Your Patients Exceptional Vision at Every Meaningful Distance1
Vision Simulation: Daytime Activity
Clareon® PanOptix® Provides Patients with a More Natural Intermediate Focal Point at 60 cm4
Our natural intermediate focal point is at arm’s length5-8
Clareon® PanOptix® offers a more comfortable intermediate distance for your patients at 60 cm vs 80 cm4
Other IOLs
A person would need to be over 2 meters tall for 80 cm to be considered a comfortable arm's length.5-8
Proven Patient Satisfaction
Patients are saying yes to the PanOptix® IOL1
Data Collected 6 Months Post-op
*n=127
†Response to the following question on IOLSAT questionnaire (Ver. 1.0, Dec. 20, 2018) at 6 months post-op: “Given your vision today, if you had to do it all over, would you have the same lenses implanted again?”
More than 9 out of 10
Patients
Reported Complete
Spectacle Independence
Patients reporting spectacle independence no longer used correction for near, intermediate or distance vision.9
PanOptix® Uses Patented ENLIGHTEN® Technology
See How ENLIGHTEN® Optical Technology Works
To make it possible to achieve 20/20 near, intermediate and distance vision – the PanOptix® IOL is equipped with a patented lens design that allows for the three optimally placed focal points.1
PanOptix® is Engineered to Optimise Light Utilisation
PanOptix® was Recognised with Prestigious Prix Galien Award for “Best Medical Technology”
Prix Galien is an international award recognising innovative therapies. Largely considered the Nobel Prize of the biopharmaceutical and medical technology industries, Prix Galien honours innovations rigorously selected as life-changing therapeutics each year.
PanOptix® is the Most Implanted Trifocal IOL in the World*
With over 2.2 million implants, PanOptix® is the most-implanted trifocal IOL worldwide and delivers an exceptional high-quality visual experience from far to near.1,9,12-14*
*Based on global Clareon® PanOptix® and AcrySof® PanOptix® unit sales 2021-2022.
Clinical Support
Technical Specifications14
*Based on an average pseudophakic human eye using an SRK/T optical A-constant of 119.1
Instructions for Use (IFU)
For a full list of indications, contraindications and warnings, please visit ifu.alcon.com and refer to the relevant product’s instructions for use.
Alcon Experience Academy
For relevant training content from industry thought leaders
References
1. Modi S, et al. Visual and patient-reported outcomes of a diffractive trifocal intraocular lens compared with those of a monofocal intraocular lens. Ophthalmology. 2021;128(2):197-207.
2. Bohm M, et al. Defocus curves of 4 presbyopia-correcting IOL designs: Diffractive panfocal, diffractive trifocal, segmental refractive, and extended-depth-of-focus. J Cataract Refract Surg. 2019;45:1625-1636.
3. Kohnen T, Herzog M, Hemkeppler E, et al. Visual performance of a quadrifocal (trifocal) intraocular lens following removal of the crystalline lens. Am J Ophthalmol. 2017;184:52-62. doi:10.1016/j.ajo.2017.09.016
4. Lwowski C, et al. Visual and patient-reported factors leading to satisfaction after implantation of diffractive EDOF and trifocal intraocular lenses. J Cataract Refract Surg. 2021 Aug 18. doi: 10.1097/j.jcrs.0000000000000780
5. Charness N, et al. Monitor viewing distance for younger and older workers. Proc Hum Factors Ergon Soc Annu Meet. 2008;52:1614-1617.
6. Average of American OSHA, Canadian OSHA and American Optometric Association Recommendations for Computer Monitor Distances. www.aoa.org. July 2015.
7. Plagenhoef S, et al. Anatomical data for analyzing human motion. Research Quarterly for Exercise and Sport. 1983;54,169-178.
8. What is the average male height? Average Height. http://www.averageheight.co/average-male-height. Accessed July 6, 2015
9. ZHU et.al. Rate of Complete Spectacle Independence with a Trifocal IOL (PanOptix): A Systematic Literature Review and Meta-Analysis. Presentation at 2022 ASCRS; April 2022; Washington, D.C.
10. Alcon Data on File, 2014. [TDOC-0018723]
11. Alcon Data on File, 2015. [TDOC-0051365]
12. Market Scope 2022 IOL Market Report.
13. Alcon Data on File, 2022. [REF-18881]
14. Clareon® PanOptix® Trifocal IOL Directions for Use.
For indications, contraindications and warnings please refer to the relevant product's instruction for use.